MedTrace Logo

Registry of Aortic Valve Bioprostheses Established by Catheter

NCT01777828 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2025-02-14

No results posted yet for this study

Summary

The aim of this registry is to evaluate the overall survival up to 10 years of patients with aortic valve bioprostheses implanted via the transarterial or transapical route. Data from the register is enhanced by matching it with continuous data in the SNDS.

Mandated by the French health authorities, this registry must be maintained as part of the management of any patient undergoing transarterial or transapical aortic valve bioprosthesis implantation.

Participation in the registry is offered to all subjects eligible for bioprosthesis implantation.

Conditions

  • Transcatheter Aortic Valve Implantation

Sponsors & Collaborators

  • French Cardiology Society

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2033-02-28
Completion
2034-02-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01777828 on ClinicalTrials.gov